BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28671137)

  • 1. What do we know about Late Onset Huntington's Disease?
    Chaganti SS; McCusker EA; Loy CT
    J Huntingtons Dis; 2017; 6(2):95-103. PubMed ID: 28671137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mid-age-onset and late-onset Huntington's disease in Finnish patients.
    Sipilä JOT; Kauko T; Päivärinta M; Majamaa K
    J Neurol; 2017 Oct; 264(10):2095-2100. PubMed ID: 28849405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.
    Petracca M; Di Tella S; Solito M; Zinzi P; Lo Monaco MR; Di Lazzaro G; Calabresi P; Silveri MC; Bentivoglio AR
    Eur J Neurol; 2022 Jul; 29(7):1940-1951. PubMed ID: 35357736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: a claims‑based retrospective cohort study.
    To TM; Ta JT; Patel AM; Arndorfer S; Abbass IM; Gandhy R
    J Med Econ; 2023; 26(1):862-870. PubMed ID: 37350423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Onset Huntington Disease: Phenotypic and Genotypic Characteristics of 10 Cases in Argentina.
    Rojas NG; Ziliani JE; Cesarini ME; Etcheverry JL; Da Prat GA; McCusker E; Gatto EM
    J Huntingtons Dis; 2019; 8(2):195-198. PubMed ID: 31045517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset Huntington disease: An Italian cohort.
    Volpi E; Terenzi F; Bagnoli S; Latorraca S; Nacmias B; Sorbi S; Piacentini S; Ferrari C
    J Clin Neurosci; 2021 Apr; 86():58-63. PubMed ID: 33775347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington's Disease Patients.
    Anil M; Mason SL; Barker RA
    J Huntingtons Dis; 2020; 9(3):275-282. PubMed ID: 32675419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset Huntington's disease: diagnostic and prognostic considerations.
    Koutsis G; Karadima G; Kladi A; Panas M
    Parkinsonism Relat Disord; 2014 Jul; 20(7):726-30. PubMed ID: 24721491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic characteristics of late-onset Huntington's disease.
    Oosterloo M; Bijlsma EK; van Kuijk SM; Minkels F; de Die-Smulders CE
    Parkinsonism Relat Disord; 2019 Apr; 61():101-105. PubMed ID: 30528461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Family History on the Clinical Features of Huntington's Disease.
    Kringlen G; Kinsley L; Aufox S; Rouleau G; Bega D
    J Huntingtons Dis; 2017; 6(4):327-335. PubMed ID: 28984613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset Huntington's disease with 40-42 CAG expansion.
    Capiluppi E; Romano L; Rebora P; Nanetti L; Castaldo A; Gellera C; Mariotti C; Macerollo A; Cislaghi MG
    Neurol Sci; 2020 Apr; 41(4):869-876. PubMed ID: 31820322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult-onset Huntington's disease that presented without chorea.
    Iwata A; Ishihara K; Tsuji S
    Intern Med; 2013; 52(18):2121-2. PubMed ID: 24042524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Molecular Features of Late Onset Huntington Disease in a Peruvian Cohort.
    Cornejo-Olivas MR; Inca-Martinez MA; Espinoza-Huertas K; Veliz-Otani D; Velit-Salazar MR; Marca V; Ortega O; Cornejo-Herrera IF; Lindo-Samanamud S; Mora-Alferez P; Mazzetti P
    J Huntingtons Dis; 2015; 4(1):99-105. PubMed ID: 26333261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
    Paulsen JS; Long JD; Ross CA; Harrington DL; Erwin CJ; Williams JK; Westervelt HJ; Johnson HJ; Aylward EH; Zhang Y; Bockholt HJ; Barker RA;
    Lancet Neurol; 2014 Dec; 13(12):1193-201. PubMed ID: 25453459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huntington's disease: clinical correlates of disability and progression.
    Mahant N; McCusker EA; Byth K; Graham S;
    Neurology; 2003 Oct; 61(8):1085-92. PubMed ID: 14581669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary analysis of Huntington's Disease in South Korea.
    Shin CW; Choi YJ; Kim M; Jeon BS
    J Huntingtons Dis; 2013; 2(1):83-7. PubMed ID: 25063431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.
    Andrew SE; Goldberg YP; Kremer B; Telenius H; Theilmann J; Adam S; Starr E; Squitieri F; Lin B; Kalchman MA
    Nat Genet; 1993 Aug; 4(4):398-403. PubMed ID: 8401589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing.
    Ramos-Arroyo MA; Moreno S; Valiente A
    J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):337-42. PubMed ID: 15716522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.